Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Barnes

Showing results (441-450 of 474) with videos related to

Pageof 48
Sort By:
Glycobiology|May 22, 2023
Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detectionMatthew R Kudelka, Wei Gu, Yasuyuki Matsumoto, et al.
The Lancet. Child & Adolescent Health|May 16, 2025
Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trialShihab Hameed, Elizabeth H Barnes, Julie Briody, et al.
Clinical and Translational Radiation Oncology|October 5, 2020
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancerA Hunt, I Hanson, A Dunlop, et al.
Allergy|July 27, 2023
Immunoglobulin G4 in eosinophilic esophagitis: Immune complex formation and correlation with disease activityJonathan G Medernach, Rung-Chi Li, Xiao-Yu Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationStefan O Ciurea, Peter F Thall, Denái R Milton, et al.
American Journal of Medical Genetics. Part A|June 16, 2016
Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndromeAngela E Lin, Caroline Michot, Valerie Cormier-Daire, et al.
BMC Cancer|March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaR Mercieca-Bebber, E H Barnes, K Wilson, et al.
Plos One|October 13, 2020
Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trialMohammad Alfelali, Elizabeth A Haworth, Osamah Barasheed, et al.
Neuro-Oncology|May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU studyHao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2018
Specific IgG<sub>4</sub> antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitisAlexander J Schuyler, Jeffrey M Wilson, Anubha Tripathi, et al.
Pageof 48

Showing results (441-450 of 474) with videos related to

Sort By:
Pageof 48
Glycobiology|May 22, 2023
Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detectionMatthew R Kudelka, Wei Gu, Yasuyuki Matsumoto, et al.
The Lancet. Child & Adolescent Health|May 16, 2025
Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trialShihab Hameed, Elizabeth H Barnes, Julie Briody, et al.
Clinical and Translational Radiation Oncology|October 5, 2020
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancerA Hunt, I Hanson, A Dunlop, et al.
Allergy|July 27, 2023
Immunoglobulin G4 in eosinophilic esophagitis: Immune complex formation and correlation with disease activityJonathan G Medernach, Rung-Chi Li, Xiao-Yu Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationStefan O Ciurea, Peter F Thall, Denái R Milton, et al.
American Journal of Medical Genetics. Part A|June 16, 2016
Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndromeAngela E Lin, Caroline Michot, Valerie Cormier-Daire, et al.
BMC Cancer|March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaR Mercieca-Bebber, E H Barnes, K Wilson, et al.
Plos One|October 13, 2020
Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trialMohammad Alfelali, Elizabeth A Haworth, Osamah Barasheed, et al.
Neuro-Oncology|May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU studyHao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2018
Specific IgG<sub>4</sub> antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitisAlexander J Schuyler, Jeffrey M Wilson, Anubha Tripathi, et al.
Pageof 48